Page 142 of 291 · 8,722 total

patent instituted · Dec 13, 2024

Arm Ltd et al. v.DAEDALUS PRIME LLC

· IPR2025-00207

Arm Ltd et al. successfully convinced the PTAB to institute an IPR against DAEDALUS PRIME LLC's patent, challenging claims based on obviousness over multiple prior art references. The Board accepted that a reasonable likelihood of prevailing existed on at least one claim challenge, moving the case into the merits phase.

patent instituted · Dec 13, 2024

Arm Ltd et al. v.DAEDALUS PRIME LLC

· IPR2025-00207

The Director granted review and vacated a denial of institution for Arm Ltd against DAEDALUS PRIME LLC, referring the IPR back to the Board after parallel litigation was dismissed.

patent terminated or settled · Dec 12, 2024

Intel Corporation et al. v.Collision Communications, Inc.

· IPR2025-00302

Intel, Lenovo, and Motorola filed a motion to dismiss their IPR against Collision Communications. The PTAB granted the motion, dismissing the petition and terminating the proceeding.

patent · Dec 12, 2024

Lenovo (United States) Inc. et al. v.Collision Communications, Inc.

· IPR2025-00284

Lenovo and Motorola filed a motion to dismiss their IPR against Collision Communications, arguing good cause to withdraw before institution, citing prior PTAB precedent and a denied related Samsung IPR.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Entegris contests Inpria’s request for Director Review of the PTAB’s institution of an IPR, arguing that Lam Research is not a real party in interest and that Inpria’s claim‑construction arguments are untimely.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Entegris seeks rehearing of the USPTO’s denial to institute an IPR against Inpria’s ’903 patent covering semiconductor‑material compounds. The petition argues the Director’s retroactive rescission of guidance and misapplication of Fintiv factors violated statutory and due‑process requirements.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Inpria seeks director review to vacate the PTAB’s institution of an IPR against its ’903 patent, arguing Entegris failed the real‑party‑in‑interest test and that the Board’s claim construction conflicts with a Delaware court ruling.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

The USPTO granted Entegris’s rehearing request, vacated the earlier discretionary denial, and sent the IPR on Inpria’s lithography patent back to the Board for institution after a related district‑court case settled.

patent terminated or settled · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Entegris and Inpria have settled their dispute over U.S. Patent No. 11,673,903 and jointly moved to terminate the inter partes review. The Board had previously instituted the proceeding but no merits were decided.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Entegris filed a motion to seal its confidential response to Inpria’s request for director review in IPR2025-00267, citing the need to protect trade‑secret information.

patent instituted · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

The PTAB instituted inter partes review of Entegris' challenge to Inpria's 11,673,903 patent covering high‑purity organotin compounds, finding a reasonable likelihood of unpatentability.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Entegris and Inpria filed a joint request to keep their settlement agreement confidential under 35 U.S.C. § 317(b) and related regulations, arguing that disclosure would harm their business interests.

patent · Dec 12, 2024

X Corp. v.Sterling Computers Corporation

· IPR2025-00299

X Corp. petitions the PTAB to invalidate Sterling Computers’ 7,716,217 patent covering email relevance scoring, asserting that all 22 claims are obvious over prior art such as Dumais, Kircher, Krug, and Marston. The petition also argues that discretionary denial is unwarranted.

patent · Dec 12, 2024

Entegris, Inc. v.Inpria Corporation

· IPR2025-00267

Entegris has filed an IPR petition seeking cancellation of claims 1‑4 and 6‑10 of Inpria’s ’903 patent, asserting that the claimed high‑purity organotin compositions are fully disclosed in earlier literature. The petition challenges the patent on anticipation and obviousness grounds and argues that Inpria’s examiner‑era declarations were misleading.

patent · Dec 12, 2024

Intel Corporation et al. v.Collision Communications, Inc.

· IPR2025-00303

Intel, Lenovo and Motorola have filed an IPR petition seeking to invalidate claims 1‑5 of Collision Communications’ ’703 patent covering iterative multi‑user detection. The petition relies on multiple prior‑art references to argue obviousness and urges the Board to institute the review.

patent · Dec 12, 2024

Intel Corporation et al. v.Collision Communications, Inc.

· IPR2025-00302

Intel, Lenovo, and Motorola have filed an IPR petition seeking to invalidate Collision Communications’ ’651 patent covering multi‑user detection. They rely on obviousness over Fuller‑Reznik and Frank‑Zha combinations and argue that discretionary denial factors favor institution.

patent · Dec 12, 2024

Intel Corporation et al. v.Collision Communications, Inc.

· IPR2025-00301

Intel, Lenovo and Motorola seek to invalidate Collision Communications' 9,814,071 patent on multi‑user detection, arguing the claims are obvious over prior art such as Jin, Baum, Tsai and Vrzic. The petition emphasizes new arguments and opposes discretionary denial, requesting institution of the IPR.

patent · Dec 12, 2024

Lenovo (United States) Inc. et al. v.Collision Communications, Inc.

· IPR2025-00285

Lenovo and Motorola filed an IPR petition challenging Collision Communications’ ’505 patent covering multi‑user detection. The petition asserts obviousness over Hottinen/Lilleberg and Zimmerman/Lilleberg and argues that discretionary denial is unwarranted.

patent · Dec 12, 2024

Lenovo (United States) Inc. et al. v.Collision Communications, Inc.

· IPR2025-00284

Lenovo and Motorola Mobility have filed an IPR petition challenging Collision Communications' 8,089,946 patent covering multi‑user detection modems. They assert three obviousness grounds based on Walton, Learned, and Quigley prior art. The petition seeks institution and argues discretionary denial is unwarranted.

patent instituted · Dec 12, 2024

X Corp. v.Sterling Computers Corporation

· IPR2025-00299

X Corp.'s IPR petition against Sterling Computers Corporation's patent (7716217) was instituted, finding a reasonable likelihood of prevailing on obviousness grounds. The Board found that combining Kircher and Krug would motivate a POSITA to improve relevance scoring in email content ranking.

patent denied · Dec 12, 2024

Intel Corporation et al. v.Collision Communications, Inc.

· IPR2025-00301

The PTAB denied institution of an IPR filed by Intel and others against Collision Communications regarding wireless multiuser detection claims. The denial was based on the Fintiv factors, noting that the parallel district court trial date was too close to the Board's statutory deadline.

patent denied · Dec 12, 2024

Lenovo (United States) Inc. et al. v.Collision Communications, Inc.

· IPR2025-00285

The PTAB denied Lenovo and Motorola's request to institute IPR against Collision Communications regarding patent 6947505. The denial was based on the Petitioner failing to show a reasonable likelihood of success, mirroring a prior adverse ruling in related proceedings.

patent · Dec 11, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00003

Halozyme has filed a Director Review request asking the PTAB to overturn its institution of a post‑grant review of the ’600 hyaluronidase protein patent, arguing procedural errors and an improper claim construction.

patent instituted · Dec 11, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00003

Merck Sharp & Dohme LLC filed a response defending the institution of a post‑grant review of Halozyme’s enzyme patent. The brief rebuts Halozyme’s eligibility, claim‑construction, and Fintiv arguments, emphasizing that the Board’s earlier findings remain sound.

patent · Dec 11, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00003

Merck files a PGR petition challenging Halozyme’s protein‑based contraceptive patent, arguing the claims lack written description and enablement. The reply emphasizes that the specification does not support the broad genus of modified PH20 polypeptides claimed.

patent denied · Dec 11, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00003

The USPTO Director denied Merck’s request for a review of the PTAB’s institution decisions in four Halozyme patent cases, leaving the institution findings intact.

patent terminated or settled · Dec 11, 2024

Ericsson, Inc. v.Motorola Mobility LLC

· IPR2025-00174

Ericsson and Motorola reached a settlement and jointly moved to terminate IPR2025-00174 concerning patent 11,184,130. The Board is asked to end the proceeding under 35 U.S.C. §317 before any merits are decided.

patent · Dec 11, 2024

Rocket Media, LLC d/b/a Launch Labs v.Fullthrottle Technologies, LLC et al.

· IPR2025-00149

Fullthrottle Technologies contests Rocket Media’s IPR petition targeting claims 1‑36 of its ’219 patent. The owner argues the cited prior art fails to teach essential claim limitations and lacks a motivation to combine, and urges denial under § 314(a) due to parallel district‑court litigation.

patent terminated or settled · Dec 11, 2024

Ericsson, Inc. v.Motorola Mobility LLC

· IPR2025-00174

Ericsson and Motorola Mobility have settled their dispute over U.S. Patent 11,184,130 and jointly moved to terminate the pending inter partes review. The Board is asked to dismiss the proceeding under 35 U.S.C. §317.

patent · Dec 11, 2024

Rocket Media, LLC d/b/a Launch Labs v.Fullthrottle Technologies, LLC et al.

· IPR2025-00148

Fullthrottle Technologies argues that Rocket Media’s IPR petition for claims 1‑20 of U.S. Patent 11,556,947 fails because the cited prior art lacks key limitations and there is no motivation to combine the references. The response also seeks discretionary denial under § 314(a) due to parallel district‑court litigation.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →